Siren »

Bicara Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Bicara Therapeutics shares owned by Siren from 13F filings

Historical chart of Siren investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $78M 3.1M 25.47

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Deerfield Management Company
Braidwell
T. Rowe Price Associates
Fairmount Funds Management
Baker Bros. Advisors
Blackstone Group
First Turn Management
Vestal Point Capital
Point72 Asset Management
Woodline Partners
OrbiMed Advisors
Citadel Advisors

View all funds holding Bicara Therapeutics